The Ratios of CD8⁺ T Cells to CD4⁺CD25⁺ FOXP3⁺ and FOXP3^- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer

• Claudia C. Preston,

  Affiliation Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Matthew J. Maurer,

  Affiliation Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Ann L. Oberg,

  Affiliation Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Daniel W. Visscher,

  Affiliation Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Kimberly R. Kalli,

  Affiliation Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Lynn C. Hartmann,

  Affiliation Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Ellen L. Goode ,

  Contributed equally to this work with: Ellen L. Goode, Keith L. Knutson

  * E-mail: egoode@mayo.edu (ELG); kknutson@vgtifl.org (KLK)

  ¶ELG and KLK are joint senior authors on this work.

  Affiliation Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Keith L. Knutson

  Contributed equally to this work with: Ellen L. Goode, Keith L. Knutson

  * E-mail: egoode@mayo.edu (ELG); kknutson@vgtifl.org (KLK)

  ¶ELG and KLK are joint senior authors on this work.

  Affiliations Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America, Vaccine and Gene Therapy Institute, Port St. Lucie, Florida, United States of America

  ⨯